CYTOKINETICS INC (CYTK)

Lee Sung 🟡 adjusted position in 38.7K shares (7 derivative) of CYTOKINETICS INC (CYTK) at $82.30 ($6.8M) Transaction Date: Jun 24, 2026 | Filing ID: 000071

Register to leave comments

  • News bot June 29, 2026, 10:24 p.m.

    🔍 Lee Sung (Executive)

    Company: CYTOKINETICS INC (CYTK)

    Report Date: 2026-06-24

    Transaction Summary:

    • Total transactions: 15
    • Derivative instruments: 7
    • Holdings reported: 0
    • Total shares acquired: 38,730
    • Total shares sold: 77,460

    Detailed Transactions and Holdings:

    • Acquired 23,370 shares of Common Stock at $48.51 per share (Direct)
      Date: 2026-06-24 | Code: M | equity_swap_involved: 0 | shares_owned_after: 86,591.00 | transaction_form_type: 4
    • Acquired 9,307 shares of Common Stock at $44.36 per share (Direct)
      Date: 2026-06-24 | Code: M | equity_swap_involved: 0 | shares_owned_after: 95,898.00 | transaction_form_type: 4
    • Acquired 2,817 shares of Common Stock at $44.36 per share (Direct)
      Date: 2026-06-24 | Code: M | equity_swap_involved: 0 | shares_owned_after: 98,715.00 | transaction_form_type: 4
    • Acquired 1,113 shares of Common Stock at $48.51 per share (Direct)
      Date: 2026-06-24 | Code: M | equity_swap_involved: 0 | shares_owned_after: 99,828.00 | transaction_form_type: 4
    • Acquired 188 shares of Common Stock at $44.36 per share (Direct)
      Date: 2026-06-24 | Code: M | equity_swap_involved: 0 | shares_owned_after: 100,016.00 | transaction_form_type: 4
    • Acquired 822 shares of Common Stock at $44.36 per share (Direct)
      Date: 2026-06-24 | Code: M | equity_swap_involved: 0 | shares_owned_after: 100,838.00 | transaction_form_type: 4
    • Acquired 1,113 shares of Common Stock at $48.51 per share (Direct)
      Date: 2026-06-24 | Code: M | equity_swap_involved: 0 | shares_owned_after: 101,951.00 | transaction_form_type: 4
    • Sold 38,730 shares of Common Stock at $82.3 per share (Direct)
      Date: 2026-06-24 | Code: S | equity_swap_involved: 0 | shares_owned_after: 63,221.00 | transaction_form_type: 4
    • Sold 23,370 shares of Non-Qualified Stock Option (Right to Buy) at $48.51 per share (Derivative)
      Date: 2026-06-24 | Code: M | Expires: 2034-05-30 | Exercise: 2025-06-02 | equity_swap_involved: 0 | shares_owned_after: 30,047.00 | transaction_form_type: 4
    • Sold 9,307 shares of Non-Qualified Stock Option (Right to Buy) at $44.36 per share (Derivative)
      Date: 2026-06-24 | Code: M | Expires: 2035-03-13 | Exercise: 2025-04-14 | equity_swap_involved: 0 | shares_owned_after: 32,019.00 | transaction_form_type: 4
    • Sold 2,817 shares of Incentive Stock Option (Right to Buy) at $44.36 per share (Derivative)
      Date: 2026-06-24 | Code: M | Expires: 2035-03-13 | Exercise: 2025-04-14 | equity_swap_involved: 0 | shares_owned_after: 6,199.00 | transaction_form_type: 4
    • Sold 1,113 shares of Non-Qualified Stock Option (Right to Buy) at $48.51 per share (Derivative)
      Date: 2026-06-24 | Code: M | Expires: 2034-05-30 | Exercise: 2025-06-02 | equity_swap_involved: 0 | shares_owned_after: 28,934.00 | transaction_form_type: 4
    • Sold 188 shares of Incentive Stock Option (Right to Buy) at $44.36 per share (Derivative)
      Date: 2026-06-24 | Code: M | Expires: 2035-03-13 | Exercise: 2025-04-14 | equity_swap_involved: 0 | shares_owned_after: 6,011.00 | transaction_form_type: 4
    • Sold 822 shares of Non-Qualified Stock Option (Right to Buy) at $44.36 per share (Derivative)
      Date: 2026-06-24 | Code: M | Expires: 2035-03-13 | Exercise: 2025-04-14 | equity_swap_involved: 0 | shares_owned_after: 31,197.00 | transaction_form_type: 4
    • Sold 1,113 shares of Non-Qualified Stock Option (Right to Buy) at $48.51 per share (Derivative)
      Date: 2026-06-24 | Code: M | Expires: 2034-05-30 | Exercise: 2025-06-02 | equity_swap_involved: 0 | shares_owned_after: 27,821.00 | transaction_form_type: 4